Your session is about to expire
← Back to Search
EVAC-PU-ETT for Ventilator Acquired Pneumonia (PreVent2 Trial)
PreVent2 Trial Summary
This trial is studying two different types of breathing tubes to see which one is better at preventing pneumonia. One of the tubes has a design feature to prevent leakage of fluids from the mouth and the back of the throat into the lower airways and lungs. The other tube is the standard tube used at most hospitals.
- Ventilator Acquired Pneumonia
PreVent2 Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.PreVent2 Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What hazards could a patient encounter while using EVAC-PU-ETT?
"Because this is a second-stage clinical trial and there are limited safety results, EVAC-PU-ETT was assigned an assessment score of 2."
Is recruitment still in progress for this experiment?
"This particular medical trial, which was initially posted on May 6th 2019 and last updated on March 7th 2022, is no longer recruiting patients. Nevertheless, there are a whopping 174 other trials that still need participants right now."
Share this study with friends
Copy Link
Messenger